Publications by authors named "Amanda Schech"

Claim this Profile
E
Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity.
Armina Kazi, Olga Goloubeva, Amanda Schech, Stephen Yu, Gauri J Sabnis

J Steroid Biochem Mol Biol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone Deacetylase Inhibitor Entinostat Inhibits Tumor-Initiating Cells in Triple-Negative Breast Cancer Cells.
Amanda Schech, Armina Kazi, Stephen Yu, Preeti Shah, Gauri Sabnis

Mol Cancer Ther· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A nude mouse model of obesity to study the mechanisms of resistance to aromatase inhibitors.
Amanda Schech, Stephen Yu, Olga Goloubeva, John McLenithan, Gauri Sabnis

Endocr Relat Cancer· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase inhibitor entinostat in combination with a retinoid downregulates HER2 and reduces the tumor initiating cell population in aromatase inhibitor-resistant breast cancer.
Amanda J Schech, Preeti Shah, Stephen Yu, Gauri J Sabnis, Olga Goloubeva

Breast Cancer Res Treat· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advances in mechanisms of resistance to aromatase inhibitors.
Saranya Chumsri, Amanda Schech, Chakkapong Chakkabat, Gauri Sabnis, Angela Brodie

Expert Rev Anticancer Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonhypoxic regulation and role of hypoxia-inducible factor 1 in aromatase inhibitor resistant breast cancer.
Armina A Kazi, Rabia A Gilani, Amanda J Schech, Saranya Chumsri, Gauri Sabnis

Breast Cancer Res· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid reverses the epithelial-mesenchymal transition and inhibits self-renewal of breast cancer cells through inactivation of NF-κB.
Amanda J Schech, Armina A Kazi, Rabia A Gilani, Angela H Brodie

Mol Cancer Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
Zoledronic acid inhibits aromatase activity and phosphorylation: potential mechanism for additive zoledronic acid and letrozole drug interaction.
Amanda J Schech, Brandon E Nemieboka, Angela H Brodie

J Steroid Biochem Mol Biol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of HER2 signaling in the tumor-initiating cell population in aromatase inhibitor-resistant breast cancer.
Rabia A Gilani, Armina A Kazi, Preeti Shah, Amanda J Schech, Saranya Chumsri

Breast Cancer Res Treat· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis